AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12614251
Drug: Tolterodine 2
RxNorm normalized name: tolterodine 2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine 2 mg twice daily plus simplified bladder training (BT)
Trial: 10325795
Drug: Sucrose administered
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose administered into the mouth
Trial: 10325795
Drug: Sucrose administered
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose administered intragastrically
Trial: 7569002
Drug: Split course
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Split course therapy
Trial: 7569002
Drug: Conventional daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional daily radiation therapy
Trial: 14711910
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (100 mg daily)
Trial: 7015797
Drug: Metoprolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100 mg once daily, increased to 200 mg if needed)
Trial: 7015797
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg once daily, increased to 200 mg if needed)
Trial: 26716547
Drug: Oral propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propranolol combined with topical timolol maleate (Experimental group A)
Trial: 26716547
Drug: Oral propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propranolol alone (Control group B)
Trial: 24868014
Drug: 15% H(2)O(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% H(2)O(2) bleaching agent with TiO_N photocatalyzed with LED/laser light (HP15)
Trial: 21738095
Drug: Physician education
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physician education in combination with motivational counseling (MC)
Trial: 17241304
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate (400 mg b.i.d.), tetracycline (500 mg q.i.d.), and metronidazole (250 mg q.i.d.)
Trial: 17241304
Drug: Levofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (500 mg b.i.d.), amoxicillin (1 g b.i.d.), and omeprazole (20 mg b.i.d.)
Trial: 3802930
Drug: Bronchodilator pretreatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilator pretreatment
Trial: 3802930
Drug: Increased dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dose oral steroid therapy
Trial: 24233256
Drug: Fiber-blend fortified
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiber-blend fortified enteral formula (FB, 15 g/L)
Trial: 24521695
Drug: Nimotuzumab (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimotuzumab (200 mg doses, first 6 doses weekly, then every 21 days for up to 1 year)
Trial: 24521695
Drug: Nimotuzumab in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimotuzumab in combination with radiotherapy
Trial: 19949030
Drug: Oral methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methylprednisolone (oMP) 1 g/day for 5 days
Trial: 19949030
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (IV MP) 1 g/day for 5 days
Trial: 17305736
Drug: Short-term topical
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term topical steroid treatment (prednisolone acetate 1% eyedrops, stopped after 6 months)
Trial: 17305736
Drug: Long-term topical
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term topical steroid treatment (prednisolone acetate 1% eyedrops, continued once a day until 12 months postoperatively)
Trial: 11797069
Drug: 0.27 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.27 g/kg alcohol
Trial: 9766764
Drug: Clonazepam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (0.5 mg h.s. adjusted to two tablets by day 10 if needed)
Trial: 9766764
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg/day for all patients initially and 40 mg/day if needed after 6 weeks)
Trial: 1912206
Drug: Positive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive treatment (TP) - positive reinforcement focused on quality of life
Trial: 1912206
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - without therapy
Trial: 895528
Drug: Tryptophan (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tryptophan (10 g orally administered)
Trial: 31522843
Drug: Antibiotic-impregnated shunt
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic-impregnated shunt (0.15% clindamycin and 0.054% rifampicin)
Trial: 27918333
Drug: Control (Patient-Controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Patient-Controlled Analgesic Morphine)
Trial: 19808215
Drug: Weekly dosing
RxNorm normalized name: selinexor
DrugBank: Selinexor (DB11942)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly dosing (QW) of epoetin alfa
Trial: 19808215
Drug: Biweekly dosing
RxNorm normalized name: Biweekly Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biweekly dosing (Q2W) of epoetin alfa
Trial: 19808215
Drug: Three times
RxNorm normalized name: WELLBUTRIN 100 MG Oral Tablet, Three Times Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three times per week dosing (TIW) of epoetin alfa
Trial: 16710858
Drug: Preoperative administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative administration of 500 mg of methylprednisolone
Trial: 11316330
Drug: Melatonin secretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin secretion estimated by overnight urinary excretion of 6-sulphatoxymelatonin
Trial: 2433932
Drug: Nimodipine 120
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nimodipine 120 mg, started within 24 hours after onset of stroke, combined with standard treatment (hemodilution using low molecular dextran)
Trial: 22186814
Drug: Single-visit endodontic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-visit endodontic therapy
Trial: 22186814
Drug: Multiple-visit endodontic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-visit endodontic therapy
Trial: 28902817
Drug: Control Group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Group (comprehensive therapy including wearing a compression knee sock, phlebotrophic drugs, and dosed walking)
Trial: 18457589
Drug: Transmural collaborative
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transmural collaborative care model including Problem Solving Treatment (PST), workplace intervention, antidepressant medication, and manual guided self-help.
Trial: 12141721
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TAA) 220 microg, two sprays/nostril once daily AM
Trial: 12141721
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 200 microg, two sprays/nostril once daily AM
Trial: 8867714
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg adrenaline
Trial: 8867714
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg adrenaline
Trial: 2277735
Drug: Chest physical
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest physical therapy (PT)
Trial: 29236943
Drug: Induction TPF
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction TPF (Docetaxel 75 mg/m2 day 1; cisplatin 75 mg/m2 day 1; 5FU 750 mg/m2/day days 1-5) plus concomitant cisplatin-RT (40 mg/m2 weekly)
Trial: 26200815
Drug: Local injection
RxNorm normalized name: Sclerosing agents for local injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local injection of methylcobalamin and lidocaine combination for 14 days (A1, B1)
Trial: 26200815
Drug: Intramuscular methylcobalamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular methylcobalamin in addition to local lidocaine injection (A0, B0)
Trial: 17607331
Drug: Duloxetine 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 120 mg/day
Trial: 15613407
Drug: Recombinant methionyl
RxNorm normalized name: Recombinant methionyl human bdnf
DrugBank: Recombinant methionyl brain-derived neurotrophic factor (DB16970)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant methionyl human leptin (r‐metHuLeptin) administration
Trial: 15613407
Drug: Recombinant methionyl
RxNorm normalized name: Recombinant methionyl human bdnf
DrugBank: Recombinant methionyl brain-derived neurotrophic factor (DB16970)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant methionyl human leptin (r‐metHuLeptin) administration for 4 or 16 weeks
Trial: 7592204
Drug: Cold dry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold dry air inhalation and exhalation
Trial: 7592204
Drug: Warm moist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm moist air inhalation and exhalation
Trial: 25134497
Drug: Automatic Self
RxNorm normalized name: AMMONIA,AROMATIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic Self Transcending Meditation (ASTM) plus Treatment as Usual (TAU)
Trial: 15996356
Drug: One-piece implants
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-piece implants (group C)
Trial: 11953624
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy focused on the calcified area (4000 impulses, 0.78 mJ/mm2, 2 sessions)
Trial: 11953624
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy focused on the origin of the supraspinatus tendon (4000 impulses, 0.78 mJ/mm2, 2 sessions)
Trial: 1993631
Drug: Misonidazole 1
RxNorm normalized name: metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misonidazole 1 g/m2 with 3.0 Gy x 10 fractions
Trial: 1993631
Drug: Misonidazole 2
RxNorm normalized name: metronidazole 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misonidazole 2 g/m2 with 5.0 Gy x 6 fractions
Trial: 6524276
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of 60 ml mepivacaine 1% with adrenaline
Trial: 6524276
Drug: Fractional injections
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional injections of 30 + 30 ml mepivacaine 1% with adrenaline (20 min interval)
Trial: 6524276
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Bolus and Fractional injections)
Trial: 31048271
Drug: Pharmacist implemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist implemented educational treatment programme
Trial: 29027034
Drug: Low-intensity LED
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity LED therapy (λ 640 ± 20 nm, 6 J/cm2)
Trial: 24619865
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) consumption (75 mg EGCG)
Trial: 12665537
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (5 g/day)
Trial: 10823096
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg i.v.
Trial: 10690141
Drug: Saline 2
RxNorm normalized name: SODIUM CHLORIDE BRONCHO-SALINE 240ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline 2 ml i.v. (Control)
Trial: 31553815
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for targeted therapy-related fatigue (CBT-TTF)
Trial: 27380540
Drug: Siponimod 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Siponimod 1.25 mg
Trial: 27380540
Drug: Siponimod 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Siponimod 0.5 mg
Trial: 27380540
Drug: Siponimod 0.25
RxNorm normalized name: siponimod 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Siponimod 0.25 mg
Trial: 20356491
Drug: Single-agent gemcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent gemcitabine (1000 mg/m² at Days 1 and 8 for a 21-day cycle)
Trial: 20356491
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus carboplatin (gemcitabine 1000 mg/m² at Days 1 and 8 and carboplatin AUC5 at Day 2 for a 21-day cycle)
Trial: 18565577
Drug: Online cessation
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Online cessation intervention with $10 weekly incentives and personalized smoking cessation messages.
Trial: 15976151
Drug: CBT+fluoxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT+fluoxetine
Trial: 10621762
Drug: Venlafaxine (200-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (200-300 mg/day)
Trial: 10621762
Drug: Paroxetine (30-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (30-40 mg/day)
Trial: 8187120
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg daily
Trial: 1687407
Drug: Steroids before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids before streptokinase infusion
Trial: 1687407
Drug: Intravenous heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous heparin and oral anticoagulants
Trial: 6355181
Drug: Dazoxiben 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dazoxiben 200 mg
Trial: 6355181
Drug: Dazoxiben (25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dazoxiben (25, 50, 100, 200 mg)
Trial: 30497093
Drug: Antioxidant administration
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant administration (α-lipoic acid, vitamin C and E)
Trial: 30497093
Drug: Antioxidant administration
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant administration in hypoxia
Trial: 28204880
Drug: γ‐cyclodextrin curcumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: γ‐cyclodextrin curcumin formulation (CW8)
Trial: 28204880
Drug: curcumin phytosome
RxNorm normalized name: Jarrow Formulas Curcumin Phytosome Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: curcumin phytosome formulation (CSL)
Trial: 28204880
Drug: formulation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: formulation of curcumin with essential oils of turmeric (CEO)
Trial: 14984727
Drug: Pentoxifylline 600
RxNorm normalized name: pentoxifylline 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline 600 mg BID (n=23)
Trial: 11590517
Drug: nelfinavir (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nelfinavir (750 mg tid), saquinavir soft-gel capsule (SGC) (800 mg tid), and stavudine (40 mg bid)
Trial: 11590517
Drug: ritonavir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ritonavir (400 mg bid), saquinavir-SGC (400 mg bid), and stavudine (40 mg bid)
Trial: 11590517
Drug: delavirdine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delavirdine (400 mg tid), saquinavir-SGC (800 mg tid), and stavudine (40 mg bid)
Trial: 19647342
Drug: Paracetamol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1 g)
Trial: 8082093
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy with cisplatin (60 mg/m2) or carboplatin (300 mg/m2), epirubicin (50 mg/m2), etoposide (100 mg/m2) and local irradiation (15 Gy total)
Trial: 8082093
Drug: Carboplatin treatment
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin treatment
Trial: 2672755
Drug: Exercise plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise plus relaxation and breathing therapy (treatment A, n = 76)
Trial: 2672755
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training only (treatment B, n = 80)
Trial: 2672755
Drug: Exercise plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise plus relaxation and breathing therapy (treatment A)
Trial: 3319629
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training only (treatment B)
Trial: 28795831
Drug: Problem-Solving Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-Solving Therapy for Suicide Prevention (PST-SP)
Trial: 23190794
Drug: Carvedilol +
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol + Lisinopril
Trial: 17344670
Drug: Weekly infusional
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly infusional 5FU (WI-FU)
Trial: 6293716
Drug: Regimen 1
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen 1 (10% mannitol, oral neomycin, intravenous cefotaxime)
Trial: 6293716
Drug: Regimen 2
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen 2 (10% mannitol, oral neomycin, intravenous cefotaxime for 24 hours postoperatively)
Trial: 6293716
Drug: Regimen 3
RxNorm normalized name: Bayer Aspirin Regimen 325mg Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen 3 (10% mannitol, oral neomycin, cefazolin sodium)
Trial: 30798587
Drug: L-carnitine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine supplementation with sofosbuvir and ribavirin (Group B)
Trial: 23713245
Drug: Guizhi Fuling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guizhi Fuling Pill (GFP) and earthworm powder (Group A)
Trial: 11773907
Drug: Low-dose milrinone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose milrinone (25 microg/kg intravenous bolus over 60 minutes followed by a 0.25 microg/kg/min infusion for 35 hours)
Trial: 11773907
Drug: High-dose milrinone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose milrinone (75 microg/kg intravenous bolus over 60 minutes followed by a 0.75 microg/kg/min infusion for 35 hours)
Trial: 9650437
Drug: Standford Hypnotic
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standford Hypnotic Susceptibility Scale, Form C (SHSS:C) administered after cold pressor pain protocol
Trial: 9650437
Drug: Standford Hypnotic
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standford Hypnotic Susceptibility Scale, Form C (SHSS:C) administered before cold pressor pain protocol
Trial: 7648148
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin plus metronidazole
Trial: 2667860
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (carisoprodol, paracetamol, and caffeine)
Trial: 31087313
Drug: Oropharyngeal administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oropharyngeal administration of colostrum (0.2 mL, 0.1 mL on either side, every 2 hours for 72 hours)
Trial: 31010430
Drug: LAFEW 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAFEW 8 g group
Trial: 31010430
Drug: LAFEW 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAFEW 6 g group
Trial: 31010430
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (8 g of milk whey protein)
Trial: 21442610
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (historical and concurrent national controls)
Trial: 19558521
Drug: Cardiac Resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac Resynchronization Therapy (CRT) on mode
Trial: 19558521
Drug: Cardiac Resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac Resynchronization Therapy (CRT) off mode
Trial: 8172113
Drug: Single nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single nutrients with antihypertensive properties